◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

Home › All stocks › ICLR

ICON PLC (ICLR) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · DIAGNOSTICS & RESEARCH · DATA UPDATED 2026-07-25

ICON PLC (ICLR) operates in the DIAGNOSTICS & RESEARCH industry and is headquartered in Dublin, Ireland with about 40,350 employees. Its market capitalization is roughly $13 billion. In the fiscal year ended 2025-12-31, ICLR reported $8.3B in revenue and $229M in net income.

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally.

Interactive charts & full statements → Open the ICLR valuation workbench →

ICLR Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-03-31	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$8.3B	$8.3B	$8.3B	$8.1B	$7.7B	$5.5B	$2.8B	$2.8B	$2.6B	$1.8B	$1.7B	$1.6B	$1.5B	$1.3B	$1.1B	$946M	$900M	$888M	$865M	$631M	$456M
Gross Profit	$2.0B	$2.2B	$2.4B	$2.4B	$2.2B	$1.5B	$808M	$832M	$769M	$727M	$705M	$666M	$600M	$491M	$397M	$334M	$359M	$380M	$376M	$276M	$199M
Gross Margin %	24.1%	26.4%	29.4%	29.6%	28.6%	27.5%	28.9%	29.6%	29.6%	41.3%	42.3%	42.3%	39.9%	36.7%	35.6%	35.3%	39.9%	42.8%	43.5%	43.8%	43.8%
Operating Income (EBIT)	$872M	$1.0B	$1.1B	$956M	$795M	$379M	$392M	$433M	$373M	$338M	$312M	$282M	$202M	$121M	$72M	$39M	$92M	$107M	$100M	$69M	$48M
Operating Margin %	10.5%	12.3%	13.3%	11.8%	10.3%	6.9%	14.0%	15.4%	14.4%	19.2%	18.7%	17.9%	13.5%	9.1%	6.5%	4.2%	10.2%	12.1%	11.5%	11.0%	10.5%
Net Income	$180M	$229M	$791M	$612M	$505M	$153M	$328M	$374M	$323M	$281M	$262M	$240M	$172M	$103M	$55M	$23M	$87M	$94M	$78M	$56M	$38M
Net Margin %	2.2%	2.8%	9.6%	7.5%	6.5%	2.8%	11.7%	13.3%	12.4%	16.0%	15.7%	15.2%	11.5%	7.7%	5.0%	2.4%	9.7%	10.6%	9.0%	8.9%	8.4%
EBITDA	—	$824M	$1.6B	$1.5B	$1.4B	$739M	$489M	$532M	$452M	$402M	$379M	$339M	$264M	$169M	$111M	$69M	$128M	$141M	$130M	$88M	$63M
Earnings Per Share (EPS)	$2.25	$2.90	$9.53	$7.40	$6.13	$2.25	$6.15	$6.88	$5.90	$5.13	$4.65	$3.97	$2.73	$1.65	$0.91	$0.37	$1.44	$1.57	$1.30	$1.88	$1.33
Shares Outstanding (M)	77M	79M	83M	83M	82M	68M	53M	54M	55M	55M	56M	60M	63M	62M	61M	61M	61M	60M	60M	30M	29M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ICLR Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Total Revenue	$2.0B	$2.2B	$2.0B	$2.0B	$2.0B	$2.0B	$2.0B	$2.1B
Gross Profit	$478M	$501M	$456M	$562M	$559M	$599M	$591M	$627M
Gross Margin %	23.5%	22.9%	22.3%	27.8%	27.9%	29.4%	29.1%	29.5%
Operating Income (EBIT)	$174M	$230M	$259M	$209M	$220M	$297M	$285M	$230M
Operating Margin %	8.5%	10.5%	12.7%	10.4%	11.0%	14.5%	14.1%	10.8%
Net Income	$105M	($110M)	$2M	$183M	$154M	$260M	$197M	$147M
Net Margin %	5.1%	-5.0%	0.1%	9.1%	7.7%	12.7%	9.7%	6.9%
EBITDA	$277M	—	$187M	$309M	$317M	$366M	$381M	$381M
Earnings Per Share (EPS)	$1.36	$-1.44	$0.03	$2.30	$1.87	$3.16	$2.36	$1.76
Shares Outstanding (M)	77M	77M	78M	80M	82M	82M	83M	83M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ICLR Free Cash Flow History

Cash flow	TTM → 2026-03-31	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	$972M	$1.0B	$1.3B	$1.2B	$563M	$829M	$595M	$413M	$264M	$383M	$259M	$280M	$170M	$221M	$114M	$20M	$87M	$255M	$81M	$43M	$50M
Capital Expenditures (CapEx)	$181M	$174M	$168M	$141M	$142M	$94M	$51M	$51M	$48M	$0M	$43M	$50M	$33M	$29M	$31M	$35M	$31M	$34M	$68M	$75M	$32M
Free Cash Flow (FCF)	$791M	$862M	$1.1B	$1.0B	$421M	$735M	$544M	$362M	$216M	$383M	$217M	$230M	$137M	$192M	$83M	($15M)	$56M	$221M	$13M	($32M)	$19M
FCF Margin %	9.5%	10.4%	13.5%	12.6%	5.4%	13.4%	19.4%	12.9%	8.3%	21.8%	13.0%	14.6%	9.1%	14.3%	7.4%	-1.6%	6.3%	24.9%	1.6%	-5.1%	4.2%
Dividends Paid	—	—	—	—	$36M	—	$13M	—	—	—	—	—	—	—	—	—	—	—	—	—	—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ICLR Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Cash from Operations (CFO)	$167M	$234M	$409M	$162M	$268M	$338M	$403M	$219M
Capital Expenditures (CapEx)	$31M	$59M	$57M	$35M	$29M	$61M	$43M	$36M
Free Cash Flow (FCF)	$136M	$175M	$352M	$128M	$239M	$277M	$359M	$183M
FCF Margin %	6.7%	8.0%	17.2%	6.3%	12.0%	13.6%	17.7%	8.6%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ICLR Balance Sheet History

Balance sheet	2026-03-31	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$16.3B	$16.3B	$16.9B	$17.0B	$17.2B	$17.4B	$3.4B	$2.9B	$2.4B	$2.2B	$1.8B	$1.7B	$1.5B	$1.4B	$1.2B	$1.0B	$950M	$908M	$867M	$693M	$476M
Cash & Cash Equivalents	$765M	$647M	$539M	$378M	$289M	$752M	$840M	$520M	$396M	$283M	$193M	$104M	$119M	$183M	$114M	$119M	$256M	$145M	$58M	$77M	$63M
Total Liabilities	$7.0B	$7.1B	$7.4B	$7.7B	$8.7B	$9.3B	$1.6B	$1.3B	$1.0B	$956M	$881M	$955M	$578M	$532M	$448M	$354M	$280M	$336M	$411M	$303M	$172M
Total Debt (Short + Long-Term)	$3.4B	$3.4B	$3.5B	$3.8B	$4.7B	$5.5B	$373M	$378M	$684M	$606M	$548M	$587M	$602M	$544M	$189M	$0M	$0M	$0M	$106M	$95M	$5M
Total Shareholders' Equity	$9.3B	$9.2B	$9.5B	$9.2B	$8.5B	$8.1B	$1.9B	$1.6B	$1.4B	$1.2B	$945M	$764M	$950M	$911M	$755M	$682M	$670M	$572M	$456M	$388M	$303M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ICLR viewer.

Other Companies in DIAGNOSTICS & RESEARCH

NTRA · Natera Inc — $38 billion
ILMN · Illumina Inc — $29 billion
GH · Guardant Health Inc — $20 billion
MEDP · Medpace Holdings Inc — $15 billion

← ICL All stocks ICMB →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.